Avantor's novel, biodegradable detergent-based solution enhances virus clearance in biomanufacturing, addressing viral contamination risks in biopharmaceuticals derived from mammalian cell culture. Offering over 6.5 log reduction value (LRV) prior to protein A capture and ensuring protein integrity without affecting yield and purity, this solution aligns with global regulatory standards for viral inactivation. Compatible with subsequent purification steps and easily removed, it meets environmental, health, and safety compliance, making it a sustainable choice for efficient virus inactivation in biopharmaceutical production.

Join for free to read